Bacterial Tonsillitis Treatment
Bacterial Tonsillitis Treatment - Related Videos
08:09
Efficient Isolation Protocol for B and T Lymphocytes from Human Palatine Tonsils
0 Views •
Cited by 11 •
2015
Palatine tonsils are a rich source of B and T lymphocytes. Here we provide an easy, efficient and rapid protocol to isolate B and T lymphocytes from human palatine tonsils. The method described has been specifically adapted for studies of the viral etiology of tonsil inflammation known as tonsillitis.
01:30
Tonsillitis I: Introduction
0 Views •
2024
Tonsillitis is inflammation of the tonsils, which are two lymphoid tissue masses at the back of the throat. This condition can cause discomfort and irritation in the throat. Etiology Three primary contributing factors have been identified. • Viruses: Viral infections are the most common cause of tonsillitis. Common viruses responsible for tonsillitis include rhinovirus, influenza, parainfluenza, Epstein-Barr virus, and adenovirus. • Bacteria: The predominant bacterium responsible for...
01:26
Tonsillitis II: Management
0 Views •
2024
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity. • Acute viral tonsillitis treatment usually involves outpatient supportive management, including analgesia (acetaminophen) and oral hydration, corticosteroids (dexamethasone), salt-water gargles, and rest. • Bacterial tonsillitis is typically treated with penicillin as the primary choice, although cephalosporins can also be effective. Antibiotic therapy with...
04:12
An In Vitro Technique to Study Antimicrobial Treatments on Bacterial Aggregates
0 Views •
2025
This video demonstrates an in vitro technique to study the impact of antimicrobial treatment on Pseudomonas aeruginosa (Pa) aggregates. Fluorescently-labeled Pa cells are grown as aggregates, mimicking the growth pattern during infection. Upon challenging the aggregates with a sublethal concentration of the antibiotic colistin, the real-time assessment of the bacteria-antibiotic interaction is performed via fluorescence microscopy.
02:56
An ATP Utilization Assay for Determining Bacterial Survival Under Antibiotics Treatment
0 Views •
2025
This video describes the simple ATP-measuring assay using luciferase glow reagent. This assay is used to quantify Neisseria gonorrhoeae survival after treatment with ceftriaxone.
FAQs
Confirmation helps clinicians distinguish bacterial illness from viral tonsillitis, which does not benefit from antibacterial treatment. Symptoms and throat examination provide the initial clinical assessment, while rapid antigen testing or culture may be appropriate when further confirmation is needed. This approach supports antibiotic stewardship by limiting unnecessary antibacterial exposure while preserving treatment for likely bacterial disease.
Antibiotics act by inhibiting bacterial growth or survival, addressing the infectious cause rather than only reducing discomfort. When the illness is bacterial, appropriate treatment can shorten symptoms and help limit transmission. Their benefit depends on using them for the correct cause, since antibacterial medicines do not provide the same value when tonsillitis is viral.
Rapid antigen testing and culture provide laboratory support when symptoms and throat examination do not fully establish the likely cause. They can help clinicians decide whether antibacterial treatment is appropriate instead of relying on symptoms alone. These tests therefore connect diagnostic evaluation with antibiotic stewardship, reducing the risk of treating viral tonsillitis with unnecessary antibacterial medicines.
Supportive care targets the symptoms that antibiotics do not immediately control, including pain, fever, and difficulty swallowing. Used alongside appropriate management of the infection, it helps make the illness more tolerable while the underlying bacterial process is addressed. This distinction is clinically useful because symptom relief and antibacterial therapy serve related but different purposes.
A typical clinical approach begins with assessing symptoms and examining the throat to estimate the likely cause. If appropriate, the clinician adds rapid antigen testing or culture before prescribing an antibiotic. Supportive measures then address pain, fever, and swallowing difficulty, while the overall plan aims to relieve illness, limit transmission, and reduce complications.
Appropriate management can shorten symptoms, reduce the likelihood of transmitting the infection, and help prevent complications associated with bacterial tonsillitis. Important complications include peritonsillar abscess and rheumatic fever. These outcomes explain why treatment decisions require both attention to the infectious cause and continued supportive care for the patient's immediate symptoms.
Antibiotic stewardship matters because not every episode of tonsillitis has a bacterial cause. Viral tonsillitis does not benefit from antibacterial treatment, so clinicians should use symptoms, throat examination, and suitable testing to guide decisions. Reserving antibiotics for likely bacterial illness supports effective care while avoiding treatment that does not address the underlying cause.